Both in Pharmaceuticals
Design Therapeutics vs Olema Pharmaceuticals
Over the past year DSGN returned +63.6% and OLMA returned −20.3%; their daily moves had a correlation of 0.21.
DSGN +63.6% OLMA −20.3%Growth of $1, one year, split-adjusted
| Metric | DSGN | OLMA |
|---|---|---|
| Price | $10.68 | $7.00 |
| Market cap | $668.4M | $612.5M |
| Today | −3.44% | −4.50% |
| 1 month | −12.7% | −15.4% |
| 6 months | −19.7% | −51.1% |
| Year to date | +13.9% | −72.0% |
| 1 year | +64.6% | −19.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $207.4M | $458.1M |
| Dividend yield | — | — |
| Volatility (60d) | 54.7% | 60.1% |
| Short % of float | 21.8% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).